麗珠醫(yī)藥集團(tuán)股份有限公司麗 珠 Ｂ2006年第一季度報告（英文）

Stock Code: 000513, 200513 Stock Name: S Livzon, Livzon-B Announcement No.: 2006-29 LIVZON PHARMACEUTICAL GROUP INC. 2006 THIRD QUARTERLY REPORT 1. I

1 LIVZON PHARMACEUTICAL GROUP INC. FIRST QUARTERLY REPORT FOR 2004 (a joint stock limited company incorporated in the People’s Republic of China with

1 Stock code: 000513, 200513 Short form of stock: Livzon Group, Livzon B No.: 2005-10 LIVZON PHARMACEUTICAL GROUP INC. 2005 FIRST QUARTERLY REPORT 1.

LIVZON PHARMACEUTICAL GROUP INC. SEMI-ANNUAL REPORT 2002 (SUMMARY) I. IMPORTANT NOTE The Board of Directors of Livzon Pharmaceutical Group Inc. (here

股本情況 麗珠醫(yī)藥集團(tuán)股份有限公司(5張) 公司經(jīng)珠海市經(jīng)濟(jì)體制改革委員會以珠體改委[1992]29號文及廣東省企業(yè)股份制試點(diǎn)聯(lián)審小組和廣東省經(jīng)濟(jì)體制改革委員會[1992]4

麗珠醫(yī)藥集團(tuán)股份有限公司2005年第三季度報告 1 Stock Code: 000513, 200513 Stock Name: Livzon Group, Livzon-B Announcement No.: 2005-25 LIVZON PHARMACEUTICAL GROUP INC. 20

1 LIVZON PHARMACEUTICAL GROUP INC. Third Quarterly Report for 2003 1. Important Notice 1.1 The board of directors of the Company confirms that there

1 LIVZON PHARMACEUTICAL GROUP INC. 2003 ANNUAL REPORT I. IMPORTANT NOTICE Important Notice: The board of directors of the Livzon Pharmaceutical Group

LIVZON PHARMACEUTICAL GROUP INC. 2004 Annual Report I. IMPORTANT NOTICE Important Notice: The board of directors (“the Board”) of the Livzon Pharmace